0000899243-18-017684.txt : 20180622
0000899243-18-017684.hdr.sgml : 20180622
20180622160040
ACCESSION NUMBER: 0000899243-18-017684
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180614
FILED AS OF DATE: 20180622
DATE AS OF CHANGE: 20180622
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Ross Leonard S
CENTRAL INDEX KEY: 0001458753
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-51122
FILM NUMBER: 18914521
MAIL ADDRESS:
STREET 1: C/O PSIVIDA CORP
STREET 2: 400 PLEASANT STREET
CITY: WATERTOWN
STATE: MA
ZIP: 02472
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: EyePoint Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001314102
STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826]
IRS NUMBER: 262774444
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0630
BUSINESS ADDRESS:
STREET 1: 480 PLEASANT STREET
STREET 2: SUITE B300
CITY: WATERTOWN
STATE: MA
ZIP: 02472
BUSINESS PHONE: 617-926-5000
MAIL ADDRESS:
STREET 1: 480 PLEASANT STREET
STREET 2: SUITE B300
CITY: WATERTOWN
STATE: MA
ZIP: 02472
FORMER COMPANY:
FORMER CONFORMED NAME: pSivida Corp.
DATE OF NAME CHANGE: 20080619
FORMER COMPANY:
FORMER CONFORMED NAME: pSivida LTD
DATE OF NAME CHANGE: 20050111
4/A
1
doc4a.xml
FORM 4/A SUBMISSION
X0306
4/A
2018-06-14
2018-06-18
0
0001314102
EyePoint Pharmaceuticals, Inc.
EYPT
0001458753
Ross Leonard S
C/O EYEPOINT PHARMACEUTICALS, INC.
480 PLEASANT STREET
WATERTOWN
MA
02472
0
1
0
0
See Remarks
Restricted Stock Units
2018-06-14
4
A
0
24840
0.00
A
Common Stock
24840
24840
D
Stock Option (right to buy)
2.04
2018-06-14
4
A
0
99360
0.00
A
2028-06-14
Common Stock
99360
99360
D
Each restricted stock unit represents a contingent right to receive one share of the Company's common stock.
The restricted stock units will vest in three equal annual installments beginning June 14, 2019. Vested shares will be delivered to the reporting person within 30 days following each respective vesting date.
The option to purchase will vest and become exercisable in three equal annual installments beginning June 14, 2019.
VP, Finance and Chief Accounting Officer
This form is being filed to correct the number of restricted stock units and stock options awarded to the reporting person.
/s/ John Mercer, Attorney-in-Fact
2018-06-22